DoP to select financial partner for pharma tech upgrade scheme
The Department of Pharmaceuticals (DoP) will soon initiate the process to select a financial institution for implementing the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) for small and medium enterprises.
Expression of interest to select the public sector financial institution will be called shortly, Joint Secretary, DoP, Mr. Navadeep Rinwa said at a Pharmaceuticals Export Promotion Council of India (Pharmexcil) event in Hyderabad recently.
PTUAS seeks to facilitate the enterprises upgrade plant and machinery to World Health Organisation-Good Manufacturing Practices (WHO-GMP) standards, thus enabling them to compete in global markets. At the heart is an interest subvention that will be available to small and medium scale pharma units having GMP compliant manufacturing facilities both for bulk drugs and pharmaceutical formulations. The scheme has got a budgetary allocation of Rs. 144-crore for two years (2018-2020), Mr. Rinwa said presenting the export performance awards instituted by Pharmexcil. Around 250 pharma SMEs are likely to benefit from the scheme. The Department, a part of Union Ministry of Chemicals and Fertilisers, has proposed interest subvention up to 6% per annum for a period of three years. The maximum loan eligible to the SMEs for upgradation will be Rs. 4-crore.
2026-09-07
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
USDA Puts Fresh Money Into Local Food Markets
-
"No available slots" returns as global shipping rates skyrocket amid multiple factors
-
Domo Chemicals’ German Subsidiary Insolvencies: Energy Costs, Weak Demand and Chinese Nylon Competition
-
The Carbon Tollbooth Is Open: EU’s CBAM Ushers in a New Era of Climate-Linked Trade
-
Sherwin-Williams Surpasses $100 Billion in Market Cap: Is This the ‘Apple Moment’ for Paint, or America’s Industrial ‘One Hundred Years of Solitude’?
-
Carbon Fiber’s Price Surge Signals a New Era of Strategic Value—and Supply Tension
-
EU Greenlights Four GM Crops—But Only at the Border
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
“Anti-Overcapacity” Backfires: China’s Chemical Industry Trapped in a Hell of Its Own Making—and Global Pushback
Recommend Reading
-
Is India’s “Luck” Finally Here? HPCL’s 10-Year LNG Deal Is a High-Stakes Bet on National Destiny
-
After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
When the Skin of Ships Gets More Expensive: A 30% Price Shock Is Quietly Rewriting the Cost Floor of Global Shipping
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
-
Sodium Chloride (NaCl): Food Grade vs Industrial Grade Uses & Safety Data
-
On March 11, the Chinese acrylonitrile market remained stable and organized
-
On March 11, the pure benzene market in China continued to see a significant decrease
-
Both Supply and Demand Increase, Lithium Carbonate Rides Out Volatility
-
Cost Push: Shandong Cyclohexanone Market Rises Recently